As of 4:01pm ET
| -0.0012 / -0.24%|
The 4 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +897.41% increase from the last price of 0.50.
The current consensus among 4 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.